Grunenthal Names New COO

The Grünenthal Group announced Mark Fladrich will take over the position as Chief Commercial Officer (CCO) responsible for the entire Global Commercial Organization. Currently Mark Fladrich is Area Vice President, Southern and Western Europe, at AstraZeneca, in the UK. He will join Grünenthal effective September 2017.

Mark Fladrich

Mark Fladrich has almost 30 years of experience in the pharmaceutical industry, and more than 20 years at AstraZeneca. He brings a broad variety of expertise, from in-market knowledge to regional and global sales and marketing to Grünenthal. Key highlights include large country management roles in Germany as well as more recently in Australia and New Zealand. Additionally, he was globally responsible for all phase III products and promoted brands and for commercial input into R&D for all stages of clinical development. In his role as CCO at Grünenthal, Fladrich will lead the entire Global Commercial organization.

"We are delighted to welcome Mark Fladrich as new member of the Corporate Executive Board. With Mark in the team, we gain an experienced and passionate commercial leader with strong business expertise, entrepreneurial spirit and track record in working closely with a R&D organization," Gabriel Baertschi, CEO of Grünenthal, said. "We are confident that together with him we will successfully lead Grünenthal towards our ambition: deliver four to five new products to patients in diseases with high unmet needs."